IMPLEMENTATION STUDY OF THE USE OF A BLOOD BIOMARKER TEST IN ALZHEIMER'S DISEASE: CLINICIAN SURVEY FROM QUIP II STUDY

被引:0
|
作者
Monane, Mark [1 ]
Carlile, Robert [2 ]
Johnson, Kim [3 ]
Gitelman, Darren [4 ]
VandeVrede, Lawren [5 ]
Jacobs, Leslie [1 ]
Braunstein, Joel [1 ]
机构
[1] C2 N DIagnost, St Louis, MO USA
[2] Palmetto Primary Care Phys, Summerville, SC USA
[3] Duke Univ, Durham, NC USA
[4] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[5] UCSF, San Francisco, CA USA
关键词
D O I
10.1093/geroni/igae098.4301
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
igae098.43
引用
收藏
页码:1348 / 1348
页数:1
相关论文
共 50 条
  • [21] A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
    Foulds, Penelope G.
    Diggle, Peter
    Mitchell, J. Douglas
    Parker, Angela
    Hasegawa, Masato
    Masuda-Suzukake, Masami
    Mann, David M. A.
    Allsop, David
    SCIENTIFIC REPORTS, 2013, 3
  • [22] Blood Pressure, Dementia and Alzheimer's Disease: The OPTIMA Longitudinal Study
    Razay, George
    Williams, Jonathan
    King, Elizabeth
    Smith, A. David
    Wilcock, Gordon
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (01) : 70 - 74
  • [23] Ambulatory Blood Pressure Characteristics of Patients with Alzheimer's Disease: A Multicenter Study from China
    Wang, Hualong
    Xu, Ying
    Ren, Rujing
    Yao, Feng
    Chen, Mei
    Sheng, Zhihua
    Guo, Xin
    Li, Yan
    Chen, Shengdi
    Wang, Gang
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (03) : 1333 - 1339
  • [24] Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study
    Agathe Vrillon
    François Mouton-Liger
    Matthieu Martinet
    Emmanuel Cognat
    Claire Hourregue
    Julien Dumurgier
    Elodie Bouaziz-Amar
    Ann Brinkmalm
    Kaj Blennow
    Henrik Zetterberg
    Jacques Hugon
    Claire Paquet
    Alzheimer's Research & Therapy, 14
  • [25] Biomarker A plus T-: is this Alzheimer's disease or not? A combined CSF and pathology study
    Vromen, Eleonora M.
    de Boer, Sterre C. M.
    Teunissen, Charlotte E.
    Rozemuller, Annemieke
    Sieben, Anne
    Bjerke, Maria
    Visser, Pieter Jelle
    Bouwman, Femke H.
    Engelborghs, Sebastiaan
    Tijms, Betty M.
    BRAIN, 2023, 146 (03) : 1166 - 1174
  • [26] Platelet Tau Protein as a Potential Peripheral Biomarker in Alzheimer's Disease: An Explorative Study
    Mukaetova-Ladinska, Elizabeta B.
    Abdell-All, Zeinab
    Andrade, Joana
    da Silva, Joaquim Alves
    Boksha, Irina
    Burbaeva, Gulnur
    Kalaria, Raj N.
    O'Brien, John T.
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (09) : 800 - 808
  • [27] Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study
    Vrillon, Agathe
    Mouton-Liger, Francois
    Martinet, Matthieu
    Cognat, Emmanuel
    Hourregue, Claire
    Dumurgier, Julien
    Bouaziz-Amar, Elodie
    Brinkmalm, Ann
    Blennow, Kaj
    Zetterberg, Henrik
    Hugon, Jacques
    Paquet, Claire
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [28] The retinal choroid as an oculovascular biomarker for Alzheimer's dementia: A histopathological study in severe disease
    Asanad, Samuel
    Ross-Cisneros, Fred N.
    Barron, Ernesto
    Nassisi, Marco
    Sultan, William
    Karanjia, Rustum
    Sadun, Alfredo A.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 775 - 783
  • [29] The need for a consensus in the use of assessment tools for Alzheimer's disease:: The Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey
    Diaz, SPR
    Gregório, PG
    Casado, JMR
    Reynish, E
    Ousset, PJ
    Vellas, B
    Salmon, E
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (08) : 744 - 748
  • [30] The use of EEG in Alzheimer's disease, with and without scopolamine - A pilot study
    Snaedal, J.
    Johannesson, G. H.
    Gudmundsson, Th. E.
    Gudmundsson, S.
    Pajdak, T. H.
    Johnsen, K.
    CLINICAL NEUROPHYSIOLOGY, 2010, 121 (06) : 836 - 841